| 摘要 |
The present invention is directed to methods and compositions for use in the diagnosis of acute megakaryoblastic leukemia. More particularly, it is shown that mutations in exon 2 of GATA-1 correlated with a predisposition to acute megakaryoblastic leukemia. Methods and compositions for exploiting this finding are described.
|
